 | | PRD_000788 | | Name: | D-phenylalanyl-N-[(4-chloropyridin-2-yl)methyl]-L-prolinamide | | Formula: | C20 H23 Cl N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000790 | | Name: | D-phenylalanyl-N-(pyridin-2-ylmethyl)-L-prolinamide | | Formula: | C20 H24 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000793 | | Name: | ACE-AEIK-CHO ALDEHYDE peptide inhibitor | | Formula: | C22 H41 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000794 | | Name: | C6H5(CH2)8-derivatized peptide inhibitor | | Formula: | C40 H63 N8 O11 P | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000795 | | Name: | D-phenylalanyl-N-(pyridin-4-ylmethyl)-L-prolinamide | | Formula: | C20 H24 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000796 | | Name: | methyl N-[(2S)-1-[[(2S,3S,5S)-5-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-3-oxidanyl-6-phenyl-1-(4-pyridin-3-ylphenyl)hexan-2-yl]amino]-3,3-dimethyl-1-oxidanylidene-butan-2-yl]carbamate | | Formula: | C39 H53 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000797 | | Name: | (2S)-2-[(N-acetyl-L-alpha-aspartyl)amino]nonanoic acid | | Formula: | C15 H26 N2 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000798 | | Name: | (3R,3aR,5R,6aR)-3-hydroxyhexahydro-2H-cyclopenta[b]furan-5-yl [(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]carbamate | | Formula: | C29 H40 N2 O8 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000799 | | Name: | N-acetyl-L-alpha-aspartyl-L-methionine | | Formula: | C11 H18 N2 O6 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000800 | | Name: | N-[3-(3-phenylisoxazol-5-yl)propanoyl]-L-alpha-glutamyl-L-alpha-glutamyl-amide | | Formula: | C22 H26 N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000801 | | Name: | N-(benzylsulfonyl)-D-leucyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | | Formula: | C26 H35 Cl N4 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000802 | | Name: | D-phenylalanyl-N-[(1-methylpyridinium-2-yl)methyl]-L-prolinamide | | Formula: | C21 H27 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000803 | | Name: | N-{3-[3-(3'-chlorobiphenyl-4-yl)isoxazol-5-yl]propanoyl}-L-alpha-glutamyl-L-alpha-glutamyl-amide | | Formula: | C28 H29 Cl N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000805 | | Name: | N-(3-biphenyl-4-ylpropanoyl)-L-alpha-glutamyl-L-alpha-glutamyl-amide | | Formula: | C25 H29 N3 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000806 | | Name: | N-(benzylsulfonyl)-3-cyclohexyl-D-alanyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | | Formula: | C29 H39 N5 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000807 | | Name: | hydrocinnamoyl-derivatized PLHSpTA peptide | | Formula: | C36 H55 N9 O12 P | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000808 | | Name: | D-peptide inhibitor | | Formula: | C70 H110 N19 O19 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000809 | | Name: | LDPPLHSpTA phosphopeptide | | Formula: | C44 H72 N12 O17 P | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000810 | | Name: | 3-(1-benzothiophen-2-yl)propanoyl-derivatized DPPLHSpTA peptide | | Formula: | C47 H67 N11 O16 P S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000811 | | Name: | N-(methylsulfonyl)-D-phenylalanyl-N-[(1-carbamimidoylpiperidin-4-yl)methyl]-L-prolinamide | | Formula: | C22 H34 N6 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000812 | | Name: | desulfo-A47934 | | Formula: | C58 H44 Cl3 N7 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000813 | | Name: | Glyco-Arylomycin | | Formula: | C53 H78 N6 O16 | | Description: | BAL4850C IS A VARIANT OF THE LIPOGLYCO ARYLOMYCIN HERE BAL4850C IS REPRESENTED BY GROUPING TOGETHER THE SEQUENCE, THE LIPID (O2U) AND RHAMNOSE. | | Definition date: | 2012-12-12 | | Last modified: | 2013-07-02 |
|
 | | PRD_000814 | | Name: | N-{[(3R,4R,7S,10R,11R)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-trien-4-yl]carbonyl}glycine | | Formula: | C23 H34 N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000815 | | Name: | peptide ACE-THR-VAL-ALC-HIS-H | | Formula: | C26 H43 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2015-07-27 |
|
 | | PRD_000816 | | Name: | DIMERIC PEPTIDE INHIBITOR | | Formula: | C78 H116 N21 O17 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
